dm+d

31009711000001109

Refrigerated Storage

ZevteraCorrevio UK Ltd

Correvio UK Ltd
Zevtera
Powder for concentrate for solution for infusion (500mg)

Contact Correvio UK Ltd in all cases where a deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

11 March 2021
London MI service

New Medicines

Zevtera (UK), Zeftera (EU,US)Staphylococcus aureus (MSSA/MRSA) bacteraemia

Information

Zevtera (UK), Zeftera (EU,US)
Licence extension / variation
Advanz Pharma
Basilea

Development and Regulatory status

None
Phase III Clinical Trials
Phase III Clinical Trials

Category

Novel cephalosporin
Rate of Meticillin-Sensitive Staphylococcus aureus (MSSA) bacteraemia cases continues to rise, with 21.7 cases per 100,000 population in 2018/19. While rates of Meticillin-Resistant Staphylococcus aureus (MRSA) bacteraemia have remained low in comparison to rates at their peak, with 1.5 per 100,000 population in 2018/19 [2].
Staphylococcus aureus (MSSA/MRSA) bacteraemia
Intravenous